Stay updated on Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.

Latest updates to the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedNew revision tag 'Revision: v3.3.4' appears and the previous tag 'Revision: v3.3.3' is removed; this is a minor administrative update with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocations are now presented under a single 'Locations' section listing Florida, North Carolina, and Virginia, with the revision updated to v3.3.3. The previous separate 'Florida Locations', 'North Carolina Locations', and 'Virginia Locations' sections have been removed.SummaryDifference0.4%

- Check46 days agoChange DetectedThe only observed change is a revision update from v3.3.1 to v3.3.2 on the page header/footer; no study content, eligibility criteria, dates, or results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now displays Revision: v3.3.1 in place of the previous Revision: v3.2.0.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page no longer displays a general funding-status notice. This change has no impact on the study information or results presented on the page.SummaryDifference0.4%

- Check75 days agoChange DetectedAdded related topics 'Ovarian cancer' and 'MedlinePlus Genetics' to the Related Topics section of the study page.SummaryDifference0.6%

Stay in the know with updates to Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.